CompletedPHASE2, PHASE3NCT02231632

The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Principal Investigator
Qihan Li, Ph.D
Institude of Medical Biology, Chinese Academy of Medical Sciences
Intervention
Live attenuated Poliomyelitis vaccine (Human Diploid Cell)(biological)
Enrollment
1200 target
Eligibility
All sexes
Timeline
2011 – 2012

Study locations (1)

Collaborators

Guangxi Center for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02231632 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials